Tue, 16th Jul 2019 16:53
(Alliance News) - Consort Medical PLC on Tuesday said Polar Capital LLP now holds a 7.4% interest in the drug manufacturing technology provider.
Prior to this transaction on Monday, Polar Capital's holding, if any, was not reported.
Consort Medical shares closed 2.7% lower on Tuesday in London at 782.00 pence each.
Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition
(Sharecast News) - Consort Medical: RBC Capital Markets upgrades to sector performer with a target price of 1,010p.
Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional
Recipharm To Make No Further Changes To Consort Medical Offer
Recipharm Extends Consort Medical Offer Deadline To February 4